Biologic Imaging is an imaging technique used in medical imaging. Contrast agents are the substances used to increase the contrast of fluids within the body in medical imaging. These substances absorb or even change external electromagnetism or ultrasound which emits radiations. With the increase in approvals of contrast agents, as well as technological advancements the biologic imaging contrast agent market is growing.
MARKET DYNAMICS
Factors driving the growth of the biologic imaging contrast agent market are increase in the demand for imaging technologies, and growth in cancer populace. However, side effects and rise in research activities are likely to hamper the growth of the market. Moreover, technology advancements in the biologic imaging contrast agent is further likely to create growth opportunities in the market.
MARKET SCOPE
The "Biologic Imaging Contrast Agent Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biologic imaging contrast agent market with detailed market segmentation by product, and end use. The biologic imaging contrast agent market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in biologic imaging contrast agent market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The biologic imaging contrast agent market is segmented on the basis of product, and end use. On the basis of type of product, the market is categorized as ct contrast reagents, magnetic resonance imaging (mri) contrast reagents, ultrasound contrast reagents. On the basis of end use, the market is categorized as hospitals, clinics, other.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biologic imaging contrast agent market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biologic imaging contrast agent market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting biologic imaging contrast agent market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biologic imaging contrast agent market in these regions.
MARKET PLAYERS
The report covers key developments in the biologic imaging contrast agent market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biologic imaging contrast agent market are anticipated to have lucrative growth opportunities in the future with the rising demand for biologic imaging contrast agent in the global market. Below mentioned is the list of few companies engaged in the biologic imaging contrast agent market.
The report also includes the profiles of key players in biologic imaging contrast agent market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.
-Bracco
-Bayer HealthCare
-Hengrui Medicine
-GE Healthcare
-YRPG
-BeiLu Pharma
-Guerbet
-Starry Pharmaceutical